Unum UK, the group safety and worker advantages supplier, has appointed Clifton Melvin, present Unum UK non-executive director and Threat Committee chair, to the position of chair of the Unum UK board .
Clifton (pictured), who will step down as Threat Committee chair, has been a non-executive director of Unum UK since November 2014.
He has been a senior unbiased director at Simply Retirement and chair of the Normal Life With Earnings Committee. He's presently chair of Sipp supplier Gaudi and the Audit Committee at Saga’s Insurance coverage Broking enterprise.
In his government profession, Clifton has held senior administration positions with AXA, KPMG, GE Capital and Credit score Suisse, the place he was the chief government of Winterthur Life UK.
Clifton will succeed Malcolm McCaig, who will likely be retiring from the UK board in August. McCaig has been a non-executive director of UK board since July 2009 and UK board chair since April 2017.
Nick Poyntz-Wright will likely be becoming a member of the UK board as a non-executive director and can succeed Clifton as Threat Committee Chair following the organisation’s August board assembly. Poyntz-Wright is a professional actuary and was beforehand CEO of Skandia and director of Lengthy-term Financial savings and Pensions on the Monetary Conduct Authority. He holds quite a few non-executive director and chair roles.
Peter O’Donnell, CEO of Unum UK, mentioned: “I sit up for welcoming Clifton and Nick into their new roles later this yr. Each deliver a wealth of business information and experience and will likely be properly positioned to assist the Board in our strategic targets and progress agenda.
“I’d additionally wish to thank Malcolm for the incredible job he has accomplished over the past decade, we are going to miss him as he has been a fantastic servant to Unum, a private assist to me and has proved to be an impressive chief of the board. I’d wish to thank him and want him each success as he continues to pursue different Directorships.”
The appointments are topic to regulatory approval.
Post a Comment